All In One Coins

All In One Coins

ICO Ended
9,815 Views
Aaress Fintech, founded by a team of developers, financial experts and blockchain technicians, has introduced its new token, All In One (AIO). AIO is an Ethereum base ERC20 token which does away with the need to select among a plethora of crypto-currencies available today. AIO allows the buyer to enjoy the price effect of all the top traded high demand coins.
The world’s first and exclusive cryptocurrency exchange as envisaged by Aaress Fintech will feature futures index and options trading in cryptocurrencies, including the Ethereum base ERC20 Tokens. The token exchange will offer advanced trading options as well, such as limit buying and selling. In addition, there will be sector specific digital currency pools that will aim to generate funding for various sectors such as construction, banking, IT, alternative healthcare and retail.
5.1
TOTAL SCORE
5.4
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 25 Aug 2017 - 25 Sept 2017
Country: Hong Kong
Token info
Ticker: AIO
Platform: Ethereum
Token Type: ERC-20
Total supply: 500,000,000 AIO
Financial
ICO Price: 1 AIO = 1 USD
Accepting: ETH
Sujit Jadhav
Founder
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Candao
"People can, DAO's do. Candao mission is to create a platform where individuals with the same business and social goals can come together to inspire, engage and build values together. Candao unlock people’s superpowers and let them tokenize the value they create, liquefy assets, connect existing ones, bring people together in order to build joint ventures, distribute profits between all involved people and unlock the value of everyone who plays different roles in everyday life."
Upcoming
Adrealm
Adrealm aims to rebuild the digital advertising ecosystem and cultivate a self-sustaining open ecosystem for all participants to achieve advertising efficiency. Built on ERC-20 standard of the Ethereum platform, Adrealm connects advertisers, service providers, content publishers, developers etc on its decentralized public ledger ensuring privacy and no third-party management of data. Thanks to its three-tier architecture made of an on-chain layer, off-chain layer, and a service layer, speed and efficiency can be guaranteed and the industry pain-points such as fraud, low-quality ads, and data leakage can be overcome. Adrealm relies on a particular consensus mechanism called Proof of Valid Traffic (PoVT) that makes high-quality ads and traffic the fundamental criteria for the operational success of transactions.
Upcoming
Apillon
Apillon is a Web3 development platform empowering developers to build in the Polkadot ecosystem. Through standard API connections, it provides the complete technology stack of connected services for creating NFT, GameFi, DeFi, and other Web3 products easily, reliably, and fast.
Active
Zwoop
Using AI and blockchain, Zwoop’s unique find engine helps shoppers find the products they want from any website, at the best available price with a single click checkout. Shoppers will be able to pay for products using cryptocurrency and ZWP tokens.
Upcoming
DATA
DATA is a blockchain project initiated and governed by Blockchain Data Foundation Limited ("Blockchain Data Foundation", or BDF from hereafter), a company limited by guarantee to be incorporated in Singapore and governed in a not-for-profit manner. This project is being developed in collaboration with Yomob International Co., Ltd. ("Yomob"), a mobile monetization-as-a-service company.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.